| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4830 | 2018 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 2910 | 2018 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2727 | 2018 |
| Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2 ML Brandi, RF Gagel, A Angeli, JP Bilezikian, P Beck-Peccoz, C Bordi, ... The Journal of clinical endocrinology & metabolism 86 (12), 5658-5671, 2001 | 2593 | 2001 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2339 | 2018 |
| Phaeochromocytoma JWM Lenders, G Eisenhofer, M Mannelli, K Pacak The Lancet 366 (9486), 665-675, 2005 | 2205 | 2005 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2188 | 2018 |
| A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients GP Rossi, G Bernini, C Caliumi, G Desideri, B Fabris, C Ferri, C Ganzaroli, ... Journal of the American College of Cardiology 48 (11), 2293-2300, 2006 | 1796 | 2006 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1770 | 2018 |
| Germ-line mutations in nonsyndromic pheochromocytoma HPH Neumann, B Bausch, SR McWhinney, BU Bender, O Gimm, ... New England Journal of Medicine 346 (19), 1459-1466, 2002 | 1721 | 2002 |
| Biochemical diagnosis of pheochromocytoma: which test is best? JWM Lenders, K Pacak, MCM Walther, WM Linehan, M Mannelli, ... Jama 287 (11), 1427-1434, 2002 | 1658 | 2002 |
| Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018 | 986 | 2018 |
| Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer cell 33 (4), 676-689. e3, 2018 | 957 | 2018 |
| Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ... Cell reports 23 (1), 181-193. e7, 2018 | 913 | 2018 |
| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 895 | 2018 |
| Adjuvant mitotane treatment for adrenocortical carcinoma M Terzolo, A Angeli, M Fassnacht, F Daffara, L Tauchmanova, PA Conton, ... New England Journal of Medicine 356 (23), 2372-2380, 2007 | 884 | 2007 |
| Pheochromocytoma: recommendations for clinical practice from the First International Symposium K Pacak, G Eisenhofer, H Ahlman, SR Bornstein, AP Gimenez-Roqueplo, ... Nature clinical practice Endocrinology & metabolism 3 (2), 92-102, 2007 | 837 | 2007 |
| Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ... Cancer cell 34 (2), 211-224. e6, 2018 | 801 | 2018 |
| Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 770 | 2018 |
| Comprehensive molecular characterization of pheochromocytoma and paraganglioma L Fishbein, I Leshchiner, V Walter, L Danilova, AG Robertson, ... Cancer cell 31 (2), 181-193, 2017 | 691 | 2017 |
